My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 109

    1.

    Systematic review: reliability of compendia methods for off-label oncology indications.

    Abernethy AP, Raman G, Balk EM, Hammond JM, Orlando LA, Wheeler JL, Lau J, McCrory DC.

    Ann Intern Med. 2009 Mar 3;150(5):336-43. Epub 2009 Feb 16. Review. Erratum in: Ann Intern Med. 2009 Apr 21;150(8):571. PMID: 19221366 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Off-label cancer drug compendia found outdated and incomplete.

    Mitka M.

    JAMA. 2009 Apr 22;301(16):1645-6. No abstract available. PMID: 19383947 [PubMed - indexed for MEDLINE]Related articles

    3.

    Controlling off-label medication use.

    Gillick MR.

    Ann Intern Med. 2009 Mar 3;150(5):344-7. Epub 2009 Feb 16.PMID: 19221367 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Compendia and anticancer therapy under Medicare.

    Tillman K, Burton B, Jacques LB, Phurrough SE.

    Ann Intern Med. 2009 Mar 3;150(5):348-50. Epub 2009 Feb 16.PMID: 19221368 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Reimbursement for cancer treatment: coverage of off-label drug indications.

    American Society of Clinical Oncology.

    J Clin Oncol. 2006 Jul 1;24(19):3206-8. Epub 2006 May 22.PMID: 16717290 [PubMed - indexed for MEDLINE]Related articles

    6.

    Off-label drug use in human immunodeficiency virus disease.

    Brosgart CL, Mitchell T, Charlebois E, Coleman R, Mehalko S, Young J, Abrams DI.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1996 May 1;12(1):56-62.PMID: 8624761 [PubMed - indexed for MEDLINE]Related articles

    7.

    Reimbursement policies constrain the practice of oncology.

    Laetz T, Silberman G.

    JAMA. 1991 Dec 4;266(21):2996-9. Erratum in: JAMA 1992 Jun 24;267(24):3287. PMID: 1820471 [PubMed - indexed for MEDLINE]Related articles

    8.

    Evaluating off-label uses of anticancer drugs: time for a change.

    Sox HC.

    Ann Intern Med. 2009 Mar 3;150(5):353-4. Epub 2009 Feb 16. No abstract available. PMID: 19221369 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Antineoplastic agents: comparing off-label uses among authoritative drug compendia.

    Thompson DF, Keefe CC.

    Hosp Formul. 1993 Jul;28(7):641-2, 647.PMID: 10127046 [PubMed - indexed for MEDLINE]Related articles

    10.

    A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

    Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G.

    Health Technol Assess. 2001;5(28):1-110. Review.PMID: 11701100 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Prioritizing future research on off-label prescribing: results of a quantitative evaluation.

    Walton SM, Schumock GT, Lee KV, Alexander GC, Meltzer D, Stafford RS.

    Pharmacotherapy. 2008 Dec;28(12):1443-52.PMID: 19025425 [PubMed - indexed for MEDLINE]Related articles

    12.

    Medicare challenges and solutions--reimbursement issues in treating the patient with colorectal cancer.

    Kaa K.

    J Manag Care Pharm. 2007 Aug;13(6 Suppl C):S19-26.PMID: 17713991 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.

    Hersh WR, Wallace JA, Patterson PK, Shapiro SE, Kraemer DF, Eilers GM, Chan BK, Greenlick MR, Helfand M.

    Evid Rep Technol Assess (Summ). 2001 Aug;(24 Suppl):1-32.PMID: 11569328 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Inadequacies of statutory drug compendia also affect the mental health field.

    Paczynski RP, Kruszewski SP.

    Ann Intern Med. 2009 Sep 1;151(5):364-5. No abstract available. PMID: 19721028 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience.

    Kocs D, Fendrick AM.

    Am J Manag Care. 2003 May;9(5):393-400; quiz 401-2.PMID: 12744301 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Use and coverage of novel cancer agents in managed care.

    Bailes JS.

    Semin Oncol. 1994 Dec;21(6 Suppl 14):34-7.PMID: 7992098 [PubMed - indexed for MEDLINE]Related articles

    17.

    Comparative assessment of four drug interaction compendia.

    Vitry AI.

    Br J Clin Pharmacol. 2007 Jun;63(6):709-14. Epub 2006 Dec 7.PMID: 17166171 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The measurement and monitoring of surgical adverse events.

    Bruce J, Russell EM, Mollison J, Krukowski ZH.

    Health Technol Assess. 2001;5(22):1-194. Review.PMID: 11532239 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Lack of drug interaction conformity in commonly used drug compendia for selected at-risk dermatologic drugs.

    Chao SD, Maibach HI.

    Am J Clin Dermatol. 2005;6(2):105-11.PMID: 15799682 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Psychometric characteristics of questionnaires designed to assess the knowledge, perceptions and practices of health care professionals with regards to alcoholic patients]

    Jaussent S, Labarère J, Boyer JP, François P.

    Encephale. 2004 Sep-Oct;30(5):437-46. Review. French. PMID: 15627048 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity